| Incorporating Biomarkers to Improve Lung Cancer Risk Prediction |
Samir Hanash |
University of Texas at MD Anderson |
PLCO |
Nov 4, 2019 |
PLCO-549 |
| Incorporating Biomarkers to Improve Lung Cancer Risk Prediction |
ZIDING FENG |
UNIVERSITY OF TX MD ANDERSON CAN CTR |
PLCO |
|
2015-0200 |
| Incorporating blood biomarker with self reported exercise in PLCO cohort |
Ehsan Irajizad |
University of Texas MD Anderson Cancer Center |
PLCO |
Oct 17, 2024 |
PLCO-1710 |
| Incorporating gender differences in lung cancer screening |
Kevin ten Haaf |
Erasmus MC |
NLST |
Feb 4, 2019 |
NLST-480 |
| Indirect comparisons of screening strategies and generalizing effects to a nationally representative population by combining trial data |
Issa Dahabreh |
President and Fellows of Harvard College on behalf of Harvard T.H. Chan School of Public Health |
PLCO |
Dec 19, 2022 |
PLCO-1130 |
| Individual and Aggregate Estimators of Socioeconomic Status in PLCO |
Martin Tammemagi |
Brock University / Henry Ford Health System |
PLCO |
Jul 1, 2006 |
2006-0243 |
| Individualized-risk based computed tomography lung cancer screening strategies: an evaluation using comparative microsimulation modeling |
Kevin ten Haaf |
Erasmus MC |
NLST |
May 2, 2014 |
NLST-70 |
| Individualized-risk based computed tomography lung cancer screening strategies: an evaluation using comparative microsimulation modeling |
Kevin ten Haaf |
Erasmus MC |
PLCO |
May 2, 2014 |
PLCO-83 |
| Individualized treatment decisions for prostate cancer using prostate cancer specific and other-cause mortality predictors |
Matthew Schipper |
University of Michigan |
PLCO |
Aug 23, 2019 |
PLCO-512 |
| Individual lung cancer survival estimation based on radiomics analysis |
Yujiao Wu |
University of Technology Sydney |
NLST |
Oct 31, 2019 |
NLST-596 |
| Infection and immunity in uterine corpus and ovarian cancers |
Kara Michels |
Albert Einstein College of Medicine |
PLCO |
Feb 1, 2023 |
2022-0037 |
| Infectious risk factors for non-Hodgkin and myeloid malignancies: a pooled analysis of prospective studies |
Lauren Teras |
American Cancer Society |
PLCO |
Jun 28, 2019 |
2019-0020 |
| Inference in ROC curves for biomrkers measured in two phase nested case control studies |
Ziding Feng |
Dept. of Biostatistics, The University of Texas MD Anderson Cancer Center |
PLCO |
Jun 30, 2017 |
PLCO-282 |
| Inflammation and Sex Hormones in Relation to Prostate Cancer Risk |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Oct 15, 2007 |
2007-0046 |
| Inflammation markers and risk of endometrial and ovarian cancer |
Nicolas Wentzensen MD |
NCI |
PLCO |
Nov 18, 2010 |
2010-0211 |
| Inflammation regulation: Gene variants and inflammatory markers in colorectal neoplasia |
Sonja Berndt |
NCI, DCEG, OEEB |
PLCO |
Aug 17, 2005 |
2005-0011 |
| Inflammation-related factors and endometrial cancer risk: an E2C2 Study |
Christina Nagle |
QIMR |
PLCO |
Apr 29, 2014 |
PLCO-81 |
| Inflammatory Markers and Risk of Colorectal Cancer |
Sonja Berndt |
NCI |
PLCO |
Aug 31, 2011 |
2011-0191 |
| Inflammatory Markers and Smoking-Associated Cancers |
Meredith Shiels |
NCI |
PLCO |
Nov 18, 2010 |
2010-0201 |
| Inflammatory Markers and Subsequent Risk of Prostate Cancer |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Jan 20, 2011 |
2010-0034 |
